Female reproductive success depends on the size and quality of a finite ovarian reserve.
Results and Discussion
The size and quality of the finite supply of immature oocytes established at birth are critical determinants of female reproductive lifespan and success (1). Paradoxically, the size of this starting ovarian reserve reflects only a minor share of the initial pool of fetal oocytes. In humans, as little as 20% of oocytes survive massive fetal oocyte attrition (FOA) to form the ovarian reserve at birth (2) . Intriguingly, since the discovery of FOA in the 1960s, the rationale and mechanisms of this conserved process remain debated. Over the ensuing decades, inadequate oocyte nutrition, oocyte self-sacrifice, and meiotic DNA damage featured prominently in models attempting to explain this phenomenon (3) . However, it remains unknown whether preventing FOA, if possible, would benefit or perturb fertility.
Previously, we implicated retrotransposon LINE-1 (L1), a highly abundant mobile element in mammalian genomes, in FOA in mice ( Fig. 1A, B ) (4) (5) (6) . While DNA methylation and other mechanisms normally repress L1 (7, 8) , epigenetic remodeling of primordial germ cells creates permissive conditions for L1 expression (9) . In male germ cells, Piwi-interacting small RNAs (piRNAs) guide DNA methylation to rapidly repress transposons, whose excessive activity could otherwise lead to DNA damage, meiotic defects and germ cell death (10) (11) (12) (13) . In contrast, oocyte genomes remain demethylated throughout meiotic prophase I and until the onset of postnatal differentiation, expressing L1 during FOA (14, 15) . In addition to correlating expression levels of L1-encoded ORF1p with DNA damage and oocyte fate, we also reported a remarkable protective effect of a reverse transcriptase inhibitor azidothymidine (AZT) on oocyte viability (4, 16, 17) . Intriguingly, AZT treatment prevents oocyte death only temporarily, until embryonic day (E) 18. 5 . We surmised that the inability of AZT to prevent FOA completely is due to the persistent endonuclease activity of L1 ORF2p (18) resulting in excessive DNA damage and subsequent activation of the DNA damage checkpoint in E18.5 oocytes (4, 19, 20) .
To test if FOA is dependent on both L1 activity and L1-instigated activation of the DNA damage checkpoint, we first examined the role of checkpoint kinase 2 (CHK2), which transduces information regarding DNA double-stranded breaks (DSBs) to downstream apoptotic machinery in the mid-pachytene stage of meiotic prophase I (21). Chk2 mutant mice are viable, fertile and, unlike in wild-type animals, unrepaired DSBs do not cause death of oocytes lacking CHK2 (19).
However, whether CHK2 has a role in FOA under physiological conditions is unknown. We first compared the number of oocytes in Chk2 -/to Chk2 +/-E15.5 ovaries at the onset of FOA. At this timepoint, there was no difference in oocyte number between Chk2 -/and Chk2 +/ovaries, suggesting that CHK2 does not impact primordial germ cell proliferation (Fig. 1C and fig. S1 ).
We also analyzed the role of CHK2 in progression through meiotic prophase I based on synaptonemal complex morphology. We found no significant difference in the percent of total oocytes in each stage of meiotic prophase I between Chk2 -/and Chk2 +/ovaries at E15.5 ( fig.   S2A ). However, in Chk2 -/ovaries at E18.5, we observed an over-representation of diplotene stage oocytes, likely spared in the absence of DNA damage checkpoint activation in midpachynema ( Fig. 1A and fig. S2B and table S1). We went on to compare oocyte number per ovary in Chk2 -/and Chk2 +/at E18.5 when approximately half of the oocytes are eliminated in wild-type mice, and at P2, the endpoint of FOA (4) . At E18.5, the oocyte number is again comparable between Chk2 -/and Chk2 +/ovaries ( Fig. 1D ). However, by P2, Chk2 -/ovaries contained significantly more oocytes than P2 Chk2 +/ovaries, and a comparable number to E18.5
Chk2 -/ovaries, suggesting no further FOA has occurred (Fig. 1E ). These observations are consistent with the timing of DNA damage checkpoint activation in mid-pachynema as measured by upregulation of the transactivating p63 (TAp63) isoform that is downstream of CHK2 to trigger apoptosis at E18.5, but not at E15.5 ( fig. S3 ). Therefore, CHK2 plays a role in FOA starting at E18.5, but not earlier.
Since the onset of CHK2 function in FOA at E18.5 coincided with the endpoint of the protective effect of AZT described previously (4) , we tested if the combination of AZT treatment inhibition and DNA damage checkpoint would prevent FOA. We first validated the previous finding that daily administration of AZT to pregnant females starting at E13.5 prevents FOA between E15.5 and E18.5 but fails to maintain this effect until P2 in control Chk2 +/mice ( Fig. 1 , C-E) (4). In contrast, AZT treatment of Chk2 -/animals preserved more oocytes by P2 than either condition alone ( Fig. 1E ). In some cases, all fetal oocytes initially generated at E15.5 persist to P2 in Chk2 -/-+AZT conditions, resulting in a maximized oocyte supply ( Fig. 1C-F) . Notably, ending AZT treatment of Chk2 -/mice at E18.5 did not maximize oocyte supply at P2 ( fig. S4 and table S2). This evidence supports our hypothesis that FOA is a consequence of L1 reverse transcriptase activity throughout meiotic prophase I and activation of DNA damage checkpoint by L1 endonuclease activity and meiotic defects beginning in mid-pachynema. fig. S6 , B-E). Specifically, gene ontology enrichment analysis in E18.5 AZT-treated whole ovaries made apparent lower mRNA expression levels of a cohort of genes involved in the complement system of innate immunity compared to untreated ovaries ( Fig. 2A-B ). In contrast, E18.5 AZT-treated oocytes showed increased expression of the CD55 gene also known as Decay Accelerating Factor DAF that protects cells from autologous complement attack ( Fig. 2B ). These observations indicated a role for the complement system in Mapping of small RNA reads to repetitive elements revealed a massive increase in antisense small RNAs targeting evolutionarily young L1MdA and L1MdT elements at E18.5 and P2 compared to E15.5 ( Fig. 3D -E and table S5). Importantly, Mili mutant P2 ovaries had negligible amounts of piRNAs based on the absence of the 26-27 nucleotide long small RNA population, proving that piRNA production at this time is Mili-dependent ( Fig. 3F ). However, we found that P2 oocytes evading FOA in Mili -/-;Chk2 -/double-mutant mice treated with AZT still downregulated L1 ORF1p levels ( Fig. 3 , G and H and table S6). Cumulatively, these results suggest that oocytes use multiple mechanisms to reduce L1 upon evading FOA, one candidate being HSP90a, expression of which negatively correlates with L1 ORF1p in human germ cells and is implicated in post-transcriptional transposon repression in mice (24, 25) . Indeed, we found that Hsp90a family genes are significantly expressed and upregulated between E15.5 and E18.5 oocytes ( Fig 3A) .
The striking reduction of L1 expression and repair of DNA breaks in oocytes evading FOA prompted us to test their differentiation and developmental capacity. To assess oocyte differentiation, we analyzed the Balbiani body, an organelle aggregate that contains the Golgi complex, mitochondria, and RNAs, and whose size increases with oocyte growth and differentiation (26). We quantified Balbiani body size at E18.5 and P2, based on Golgi content area. We found an increase in Golgi content from 40µm 2 to 70µm 2 in Chk2 +/untreated control oocytes ( Fig. 4B ). Importantly, oocytes in Chk2 -/untreated and Chk2 +/and Chk2 -/-AZT-treated conditions also experienced a significant increase in Golgi content ( Fig. 4A ). Therefore, oocytes allowed to reach the P2 stage, regardless of L1 expression or amount of DNA damage initially accumulated at E18.5, have the potential to differentiate if FOA is prevented ( Fig. 4B ).
To assess the significance of FOA for folliculogenesis, we quantified growing follicle types in P4 and P19 ovaries of Chk2 +/-, Chk2 -/-, and Chk2 -/-+AZT females. P4 is an early stage of folliculogenesis at which the transition from primordial to primary follicles occurs through encapsulation of oocytes with somatic granulosa cells. P19 stage ovaries have further progressed through folliculogenesis and contain all follicle types that form by further accumulation of granulosa cell layers and theca cells around oocytes, but before ovulation. We observed the characteristic growing follicle types at P4 and P19 in both Chk2 -/-+AZT and control ovaries, suggesting that folliculogenesis is not impeded in the absence of FOA ( Fig. 4 , C -D).
Quantification of primordial and non-primordial follicles in P4 ovaries that have evaded FOA
revealed an increased number of primordial follicles compared to controls and comparable numbers of non-primordial follicles ( Fig. 4 , C -D). P19 ovaries that do not undergo FOA also contain more follicles, but the increase observed was less significant ( Fig. 4 , C -D).
To test the consequences of possessing increased numbers of primordial follicles on fertility as a result of FOA prevention, we crossed females born to Chk2 -/-+AZT-treated females that have reached reproductive maturity to Chk2 +/males and monitored the number of litters and litter size compared to untreated Chk2 -/and Chk2 +/females. Both litter number and litter size over the course of 10 months was comparable between the three conditions, suggesting that FOA is not obligatory for fertility, nor is it detrimental to have an increased number of primordial follicles in the ovarian reserve ( Fig. 4F and table S7).
Cumulatively, this work identifies FOA as a consequence of genotoxic stress during fetal oogenesis that is triggered by excessive L1 reverse transcriptase and endonuclease activities leading to DNA damage and meiotic defects. We showed that oocytes can be manipulated to evade FOA, downregulate L1 expression, and maximize the functional ovarian reserve without disrupting oogenesis or reducing fertility. Therefore, in mammals, massive oocyte loss is not an obligatory developmental program for oogenesis. Crucially, due to the conservation of FOA and L1 expression in human oocytes, this work is of biomedical relevance for human female fertility as it identifies an avenue for the improvement of the ovarian reserve by inhibiting L1 activity.
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Materials and Methods
Animals For this study, Chk2 -/mice in a mixed C57Bl/6 and 129X1/Sv genetic background were used (27). Chk2 -/mice were backcrossed one time to C57Bl/6 to generate Chk2 +/controls. We chose Chk2 +/as a control to account for the mixed genetic background resulting in a significant increase in oocyte number compared to wild-type mice of pure C57Bl /6 background (fig. S1 ). To determine how genetic background contributed to differences in oocyte number between Chk2 -/and C57Bl/6 wild-type mice, we backcrossed Chk2 -/for 4 generations. This reduced the percent genome containing homozygous 129X1/Sv SNPs from approximately 4% to 0.03% (SNP genotyping by DartMouse, Dartmouth School of Medicine). Mili +/+ , Mili +/-, and Mili -/mice used were in C57Bl/6 genetic background. Mili -/-;Chk2 -/mice and control littermates were generated by crossing Chk2 -/and Mili +/animals. Wild-type mice of CD1 (Charles River Laboratories) genetic background were used for all quantitative PCR, mRNA and small RNA sequencing experiments unless otherwise noted. All experimental procedures were performed in compliance with ethical regulations and approved by the IACUC of the Carnegie Institution for Science.
AZT treatment 50mg/kg/day AZT was administered daily by gavage to ~8-month-old pregnant female from E13.5 until experiment end point. AZT (Sigma Aldrich, Cat# A2169) was diluted to 5mg/ml in nuclease free water, aliquoted and stored at -20°C.
Oocyte and follicle quantification
We quantified oocytes per ovary at E15.5, E18.5, and P2 using a whole-mount immunofluorescence and tissue clearing method previously described (28) . Ovaries were dissected and labeled with the germ cell-specific antibody TRA98 (29) . After immunofluorescence, samples were treated with ScaleA2 clearing reagent for 7 days, changing solution each day. Confocal imaging through the entire tissue using SP5 confocal microscope (Leica) followed by 3D reconstruction of Z-stacked images and spot and surface analysis using Imaris software (Bitplane) were performed. For statistical analysis, average number of oocytes per ovary was counted in embryos from at least 3 different litters (table S2A) . Variability between numbers due to timing of plug during the day as well as natural variation between embryos that is more apparent at earlier stages between litters and embryos. Statistical significance was determined using two-tailed unpaired Student's t-test (table S2B). In the case of Mili;Chk2 double mutants, we quantified oocytes labeled with germ cell-specific antibody TRA98 and nuclei counterstained with DAPI by scoring every 5 th section through the entire ovary, and estimating total number per ovary. Statistical significance was determined using two-tailed unpaired Student's t-test (table S6A-B).
We quantified primordial and non-primordial (primary, secondary, antral) follicles at P4 and P19 by performing immunohistochemistry and DAB staining. We quantified follicles in every 5 th section through the entire ovary, then estimated total number per ovary. Sections were labeled with the cytoplasmic germ cell marker MVH and nuclei counterstained with hematoxylin. MVHpositive follicles were quantified and categorized as primordial or non-primordial based on the number of somatic cell layers surrounding the oocyte. At least three ovaries from three different females were quantified for each experimental group and two-tailed unpaired Student's t-test used to determine statistical significance (table S7A-B).
Immunostaining
Whole-mount immunofluorescence and immunofluorescence protocols on cryosections and meiotic spreads were performed as previously described (4, 28) . For immunohistochemistry with DAB staining, ovaries were fixed in Bouin's overnight at 4°C, transferred to 70% ethanol overnight, and embedded in paraffin. Ovaries were sectioned into 10µm slices. Sections were deparaffinized by washing slides in Citrisolv (Decon Labs) 3x 15 minutes, re-hydrated through graded ethanol washes, blocked with hydrogen peroxide for 10 minutes, avidin block for 15 minutes (Vector Laboratories), biotin block (Vector Laboratories), and goat serum block (Vector Labs cat # PK-4001). Samples were incubated overnight at 4°C with anti-DDX4/MVH and for 30 minutes at room temperature with biotinylated goat anti-rabbit IgG secondary antibody (Vector Labs cat # PK-4001). Samples were incubated 30 minutes at room temperature with Vectastain ABC reagent (Vector Labs cat # PK-4001) followed by DAB detection. Slides were dipped in hematoxylin, rehydrated in ethanol, dipped in Citrisolv and mounted.
Microscopy
Imaging of whole-mount ovaries and ovary sections was performed using TCS-SP5 laserscanning confocal microscope (Leica, Buffalo Grove, IL), histological sections using Nikon Eclipse E800 microscope equipped with a Diagnostic Instruments model 2.3.1 digital camera, and meiotic spreads using Olympus BX61 microscope equipped with a Hamamatsu C4742-95 digital Camera as previously described (4, 28) . Image analysis was completed using Imaris (Bitplane) and ImageJ.
Antibodies
The following primary antibodies and dilutions were used: Anti-Germ cell-specific antigen antibody [TRA98], rat monoclonal, abcam cat. # ab82527, diluted to 1:500 for immunofluorescence. Anti-L1 ORF1p (full length protein), rabbit polyclonal, diluted to 1:500 for immunofluorescence (4) . Anti-GM130, mouse monoclonal, BD Biosciences cat. # 610822, diluted to 1:200 for immunofluorescence. Anti-phospho-Histone H2A.X (Ser139) clone JBW301, mouse monoclonal, Millipore Sigma cat. # 05-636, diluted to 1:1000 for immunofluorescence. Anti-SYCP3, rabbit polyclonal, abcam cat. # ab15093, diluted to 1:500 for immunofluorescence. Anti-PIWIL2, rabbit polyclonal, abcam cat. # ab181340, diluted to 1:50 for immunofluorescence. Anti-F4/80 antibody [CI:A3-1], rat monoclonal, abcam cat. # ab6640, diluted to 1:100 for immunofluorescence. Anti-DDX4/MVH, rabbit polyclonal, abcam cat. # ab13840, diluted to 1:200 for immunostaining on paraffin sections and 1:1000 for western blot. Anti-p63(4A4), mouse monoclonal, Santa Cruz Biotechnology cat. # sc-8431, diluted to 1:500 for western blot. The following secondary antibodies and dilutions were used: Alexa donkey ant-rabbit 488 (Invitrogen, cat # A-21206) diluted 1:1000 for immunofluorescence. Alexa donkey anti-rabbit 568 (Invitrogen, cat # A10042) diluted 1:1000 for immunofluorescence.
Alexa donkey anti-mouse 488 (Invitrogen, cat # A-21202) diluted 1:1000 for immunofluorescence. Alexa donkey anti-mouse 594 (Invitrogen, cat # A-21203) diluted 1:1000 for immunofluorescence. Alexa donkey anti-rat 647 (Invitrogen, cat # 150155) diluted 1:1000 for immunofluorescence. Western blot 6-12 whole ovaries were lysed in RIPA buffer containing 50mM Tris-HCl pH=8, 150mM NaCl, 1%NP40, 1%SDS, 1mMEDTA, and 10% glycerol. 1mM PMSF and 1mM Halt protease and phosphatase inhibitor cocktail were added to buffer just before lysis. Ovaries were homogenized using RNase-free pestle and protein quantified using BCA. Lysates were run on 12% polyacrylamide running, 4% polyacrylamide stacking gel. Proteins transferred overnight at 4°C to PVDF membrane that had been activated for 15 seconds in 100% methanol followed by 2 minutes water and 15 min in transfer buffer. Membrane rinsed with PBS + 0.05% Tween-20 and blocked with 5% nonfat milk in PBS + 0.05% Tween-20 for 1 hour at room temperature. Primary antibodies were incubated overnight at 4°C in blocking buffer. Secondary antibodies used at 1:2000 and incubated 1 hour at room temperature. Detection by ECL was performed.
Meiotic chromatin spread preparation
Ovaries were dissociated into a single-cell suspension using dissociation buffer containing 0.025% trypsin, 2.5 mg/mL collagenase, and 0.1mg/mL DNase I. One volume of Hypotonic buffer (30mM Tris-HCl, pH 8.2, 50mM sucrose, 17mM sodium citrate) was added to the cell suspension and set on nutator for 30 minutes. Cells were pelleted and supernatant replaced with 100µM sucrose, pH 8.2 solution. Approximately 600µl sucrose solution per ovary pair. Slides were dipped in fixative (1% PFA, 0.15% Triton X-100, pH 9.2) and 20µL resuspended cells pipetted along bottom edge. Cells were slowly spread around slide by tilting the slide gently. Slides were dried in humid chamber for 2 hours, then treated with 0.08% Photo-Flo (Kodak). Slides used immediately for immunostaining or stored at -80°C.
Analysis of L1ORF1p and gH2AX nuclear fluorescence Ovary sections of 8µm thickness were stained with DAPI, germ cell marker TRA98, and L1 ORF1p. Confocal stacks were taken through the section. Imaris bitplane was used to generate a surface around each DAPI-positive nucleus in TRA98-positive germ cells. Then, relative mean nuclear (RMN) fluorescence was calculated for the channel containing L1 ORF1p signal within the surface. This procedure was used in the same manner to calculate gH2AX RMN fluorescence. Each germ cell RMN value was then divided by the average of three RMN values from TRA98negative somatic cell nuclei that should not contain L1 ORF1p nor gH2AX to normalize for background fluorescence. On average, about 200 oocytes were quantified per experimental group. Oocytes come from at least 3 different ovaries and 2 different litters unless noted otherwise ( 
Analysis of Golgi element area
Ovary sections of 8µm thickness were stained with DAPI, germ cell marker TRA98 and GM130 (26). Confocal stacks were taken through the section. Imaris bitplane was used to generate a surface around each GM130-positive Balbiani body region in a TRA98-positive cell. Area of surface generated for GM130 channel was calculated. Each bar represents 70 to 200 individual oocytes measured. Oocytes come from at least 3 different ovaries and 2 different litters unless noted otherwise (table S2G) . Statistical significance was determined using two-tailed Kolmogorov-Smirnov test (table S2H) .
FACS sorting
Ovaries were dissociated into a single-cell suspension using dissociation buffer containing 0.025% trypsin, 2.5 mg/mL collagenase, and 0.1mg/mL DNase I. Cell suspensions were filtered using 40µm filter. Oocytes were FACS-sorted from remaining ovarian somatic cells based on size and complexity using forward and side scatter parameters ( fig. S6A-C) (30) . Propidium iodide treatment for 10 minutes and gating for negative red fluorescence was used to eliminate dead cells from the sort. BD FACS Aria III sorter was used.
Bulk RNA-Seq analysis RNA was extracted using Trizol reagent (Invitrogen), DNaseI-treated using TURBO DNA-free kit (Ambion), and libraries generated using ribo-zero kit. 75bp unpaired, single-end reads were sequenced on Illumina Next-seq 500 system. Remaining rRNA sequences were removed computationally using bowtie by aligning reads to mm10 rRNA genome. Reads that did not align were subsequently mapped to mm10 genome using Tophat splice aligner (31). To determine differential gene expression, cuffdiff was used followed by cummeRbund in R to obtain FPKM values and generate plots ( fig. S7A-B and table S3A-D). GO pathway enrichment analyses was performed using DAVID Bioinformatics Resources 6.8 (table S3E-H) (32, 33) .
Single-cell RNA-Seq analysis
Ovaries were dissociated into a single-cell suspension using dissociation buffer containing 0.025% trypsin, 2.5 mg/mL collagenase, and 0.1mg/mL DNase I. Cells were pelleted and washed with PBS 3 times. Viability and cell count were determined using trypan blue staining and Countess II automated cell counter. Samples with greater than 90% viability and 1 million cells per milliliter were used for sequencing. GEM generation, barcoding, and library construction were performed (table S2C-D) . N1, N1F1, and N5F1 backcrosses were compared. Oocyte number decreases with decreasing 129X1/Sv genome content, and N5F1 embryos showed oocyte number per ovary that is comparable to pure C57Bl/6 embryos. Differences in oocyte number at E15.5 with genetic background are independent of the Chk2 mutation. Chk2 +/-(N1) and Chk2 -/-(N0) results from Fig. 1C GC15_0  GC15_1  GC15AZT_0  GC15AZT_1  GC15AZT_2  GC18_0  GC18_1  GC18AZT_0  GC18AZT_1  GC18AZT_2  WO15_0  WO15_1  WO15AZT_0  WO15AZT_1  WO18_0  WO18_1 WO18AZT_0 WO18AZT_1 Table S1 . Quantification and statistical analysis for meiotic progression in Chk2+/-and Chk2-/-oocytes. Table S2 . Quantification and statistical analysis for Chk2+/-and Chk2-/-untreated and AZT-treated ovary experiments. Table S3 . Differential gene expression and gene ontology for untreated and AZT-treated oocytes and ovaries. Table S4 . Differential gene expression in untreated and AZT-treated single-cell clusters. 
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